NO20052291L - Nye bicyklsike inhibitorer av hormonsensitiv lipase - Google Patents

Nye bicyklsike inhibitorer av hormonsensitiv lipase

Info

Publication number
NO20052291L
NO20052291L NO20052291A NO20052291A NO20052291L NO 20052291 L NO20052291 L NO 20052291L NO 20052291 A NO20052291 A NO 20052291A NO 20052291 A NO20052291 A NO 20052291A NO 20052291 L NO20052291 L NO 20052291L
Authority
NO
Norway
Prior art keywords
hormone
sensitive lipase
novel bicyclic
bicyclic inhibitors
inhibitors
Prior art date
Application number
NO20052291A
Other languages
English (en)
Other versions
NO20052291D0 (no
Inventor
Guenter Mueller
Hubert Heuer
Karl-Heinz Baringhaus
Stefan Petry
Norbert Nagels
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of NO20052291L publication Critical patent/NO20052291L/no
Publication of NO20052291D0 publication Critical patent/NO20052291D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/16—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D249/18—Benzotriazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Det er beskrevet benzotriazoler med generell formel I, hvori RI - R8 har de nevnte betydningene, samt fremgangsmåter for deres fremstilling. Forbindelsene viser en hemmende virkning på den hormonsensitive lipasen.
NO20052291A 2002-10-12 2005-05-10 Nye bicyklsike inhibitorer av hormonsensitiv lipase NO20052291D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10247680A DE10247680B4 (de) 2002-10-12 2002-10-12 Neue bicyclische Inhibitoren der Hormon Sensitiven Lipase
PCT/EP2003/010765 WO2004035550A1 (de) 2002-10-12 2003-09-27 Neue bicyclische inhibitoren der hormon sensitiven lipase

Publications (2)

Publication Number Publication Date
NO20052291L true NO20052291L (no) 2005-05-10
NO20052291D0 NO20052291D0 (no) 2005-05-10

Family

ID=32038583

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052291A NO20052291D0 (no) 2002-10-12 2005-05-10 Nye bicyklsike inhibitorer av hormonsensitiv lipase

Country Status (39)

Country Link
EP (1) EP1554259B1 (no)
JP (2) JP4658607B2 (no)
KR (1) KR20050059254A (no)
CN (1) CN100366616C (no)
AR (1) AR041565A1 (no)
AT (1) ATE349433T1 (no)
AU (1) AU2003275997B8 (no)
BR (1) BR0315257A (no)
CA (1) CA2501734C (no)
CR (1) CR7717A (no)
CY (1) CY1106358T1 (no)
DE (2) DE10247680B4 (no)
DK (1) DK1554259T3 (no)
EC (1) ECSP055729A (no)
ES (1) ES2277152T3 (no)
GT (1) GT200300214A (no)
HK (1) HK1080473A1 (no)
HN (1) HN2003000316A (no)
HR (1) HRP20050325A2 (no)
IL (1) IL167907A (no)
JO (1) JO2497B1 (no)
MA (1) MA27404A1 (no)
MX (1) MXPA05003359A (no)
MY (1) MY138057A (no)
NO (1) NO20052291D0 (no)
OA (1) OA12941A (no)
PA (1) PA8585101A1 (no)
PE (1) PE20040776A1 (no)
PL (1) PL374605A1 (no)
PT (1) PT1554259E (no)
RS (1) RS51543B (no)
RU (1) RU2325385C2 (no)
SV (1) SV2004001633A (no)
TN (1) TNSN05105A1 (no)
TW (1) TWI313265B (no)
UA (1) UA79994C2 (no)
UY (1) UY28015A1 (no)
WO (1) WO2004035550A1 (no)
ZA (1) ZA200501757B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005002130A1 (de) 2005-01-17 2006-07-27 Sanofi-Aventis Deutschland Gmbh Substituierte N-Aminomethylensulfonamide, ihre Herstellung und Verwendung als Arzneimittel
DE102005026762A1 (de) 2005-06-09 2006-12-21 Sanofi-Aventis Deutschland Gmbh Azolopyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
DE102005026809A1 (de) 2005-06-09 2006-12-14 Sanofi-Aventis Deutschland Gmbh Benzothiazol-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
DE102005026808A1 (de) 2005-06-09 2006-12-14 Sanofi-Aventis Deutschland Gmbh Benzooxazol-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
DE102005048897A1 (de) * 2005-10-12 2007-04-19 Sanofi-Aventis Deutschland Gmbh Diacylindazol-derivate als Inhibitoren von Lipasen und Phospholipasen
DE102005049954A1 (de) * 2005-10-19 2007-05-31 Sanofi-Aventis Deutschland Gmbh Triazolopyridin-derivate als Inhibitoren von Lipasen und Phospholipasen
DE102005049953A1 (de) 2005-10-19 2007-04-26 Sanofi-Aventis Deutschland Gmbh Carbamoylbenzotriazol-derivate als Inhibitoren von Lipasen und Phospholipasen
FR2915198B1 (fr) 2007-04-18 2009-12-18 Sanofi Aventis Derives de triazolopyridine-carboxamides et triazolopyridine -carboxamides, leur preparation et leur application en therapeutique.
FR2915197B1 (fr) * 2007-04-18 2009-06-12 Sanofi Aventis Sa Derives de triazolopyridine-carboxamides, leur preparation et leur application therapeutique.
FR2915199B1 (fr) 2007-04-18 2010-01-22 Sanofi Aventis Derives de triazolopyridine-carboxamides et triazolopyrimidine-carboxamides, leur preparation et leur application en therapeutique.
UY31968A (es) 2008-07-09 2010-01-29 Sanofi Aventis Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos
CN102333568B (zh) * 2008-12-24 2016-01-20 比亚尔-珀特拉和Ca股份公司 药物化合物
US8329904B2 (en) * 2009-05-12 2012-12-11 Hoffmann-La Roche Inc. Azacyclic derivatives
US8440710B2 (en) * 2009-10-15 2013-05-14 Hoffmann-La Roche Inc. HSL inhibitors useful in the treatment of diabetes
US8097634B2 (en) * 2010-04-15 2012-01-17 Hoffmann-La Roche Inc. Azacyclic derivatives
WO2011140296A1 (en) * 2010-05-05 2011-11-10 Infinity Pharmaceuticals Triazoles as inhibitors of fatty acid synthase
US8722721B2 (en) * 2011-03-16 2014-05-13 Hoffmann-La Roche Inc. SEC-hydroxycyclohexyl derivatives
US8703807B2 (en) * 2011-03-17 2014-04-22 Hoffmann-La Roche Inc. Azaspirodecanone compounds
US8809384B2 (en) * 2011-03-25 2014-08-19 Hoffmann-La Roche Inc. Azaspirodecanone compounds
UA119247C2 (uk) 2013-09-06 2019-05-27 РОЙВЕНТ САЙЕНСИЗ ҐмбГ Спіроциклічні сполуки як інгібітори триптофангідроксилази
GB201321740D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic agents
WO2015089137A1 (en) 2013-12-11 2015-06-18 Karos Pharmaceuticals, Inc. Acylguanidines as tryptophan hydroxylase inhibitors
WO2016109501A1 (en) 2014-12-30 2016-07-07 Karos Pharmaceuticals, Inc. Amide compounds as tryptophan hydroxylase inhibitors
US9611201B2 (en) 2015-03-05 2017-04-04 Karos Pharmaceuticals, Inc. Processes for preparing (R)-1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanol and 1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanone
CA3119912A1 (en) 2018-11-14 2020-05-22 Altavant Sciences Gmbh A crystalline spirocyclic compound inhibitor of tryptophan hydroxylase 1 (tph1) for treating diseases or disorders associated with peripheral serotonin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1124716A (en) * 1978-10-20 1982-06-01 Michael J. Simons Blocked benzotriazole compounds as development restrainer precursors
DE19942354A1 (de) * 1999-09-04 2001-03-08 Aventis Pharma Gmbh Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one, ihre Herstellung und Verwendung in Arzneimitteln
DE60224521T2 (de) * 2001-05-05 2009-01-08 Smithkline Beecham P.L.C., Brentford Cyclische N-Aroylamine
CZ2004714A3 (cs) * 2001-12-14 2004-10-13 Novoánordiskáa@S Sloučeniny a jejich použití ke snížení aktivity lipázy citlivé vůči hormonu

Also Published As

Publication number Publication date
RS20050207A (en) 2007-08-03
TWI313265B (en) 2009-08-11
AR041565A1 (es) 2005-05-18
CY1106358T1 (el) 2011-10-12
MXPA05003359A (es) 2005-06-22
BR0315257A (pt) 2005-08-23
CA2501734A1 (en) 2004-04-29
CN1688555A (zh) 2005-10-26
DE50306134D1 (de) 2007-02-08
TW200413335A (en) 2004-08-01
PE20040776A1 (es) 2004-12-24
MY138057A (en) 2009-04-30
OA12941A (en) 2006-10-13
CN100366616C (zh) 2008-02-06
DE10247680B4 (de) 2005-09-01
PA8585101A1 (es) 2004-09-16
CR7717A (es) 2007-09-14
WO2004035550A1 (de) 2004-04-29
KR20050059254A (ko) 2005-06-17
EP1554259A1 (de) 2005-07-20
HK1080473A1 (en) 2006-04-28
NO20052291D0 (no) 2005-05-10
PL374605A1 (en) 2005-10-31
ATE349433T1 (de) 2007-01-15
DK1554259T3 (da) 2007-05-07
RU2325385C2 (ru) 2008-05-27
AU2003275997B2 (en) 2010-03-25
HN2003000316A (es) 2006-06-12
IL167907A (en) 2010-12-30
CA2501734C (en) 2011-05-31
ECSP055729A (es) 2005-07-06
JO2497B1 (en) 2009-10-05
EP1554259B1 (de) 2006-12-27
JP2011026342A (ja) 2011-02-10
RU2005114394A (ru) 2006-01-20
ZA200501757B (en) 2005-09-07
PT1554259E (pt) 2007-02-28
DE10247680A1 (de) 2004-04-22
AU2003275997B8 (en) 2010-09-30
UY28015A1 (es) 2004-04-30
SV2004001633A (es) 2004-03-19
JP4658607B2 (ja) 2011-03-23
GT200300214A (es) 2007-02-05
JP2006509734A (ja) 2006-03-23
AU2003275997A1 (en) 2004-05-04
MA27404A1 (fr) 2005-06-01
HRP20050325A2 (en) 2005-06-30
UA79994C2 (en) 2007-08-10
TNSN05105A1 (en) 2007-05-14
RS51543B (en) 2011-06-30
ES2277152T3 (es) 2007-07-01

Similar Documents

Publication Publication Date Title
NO20052291L (no) Nye bicyklsike inhibitorer av hormonsensitiv lipase
NO20070529L (no) Kinazolindionderivater som parp-inhibitorer
NO20070557L (no) Ftalazinderivater som PARP-inhibitorer
NO20070532L (no) Substituerte 2-alkyl-kinazolinonderivater som PARP-inhibitorer
NO20065114L (no) Inhibitorer av IAP
NO20082476L (no) Bicykliske forbindelser med kinaseinhiberende aktivitet
NO20062950L (no) 5,7-diaminopyrazolo `43-Dlpyrimidiner med PDE-5 inhiberende aktivitet
NO20090202L (no) Prolylhydroksylaseinhibitorer
NO20080981L (no) Nitrocatechol-derivater som COMT-inhibitorer
NO20052864L (no) Nye hydroksyindoler, deres anvendelse som fosfordiesterase 4 inhibitorer samt fremstilling av forbindelser
NO20071125L (no) Substituerte indolyl-alkyl-aminoderivater som nye inhibitorer av histondeacetylase
NO20063129L (no) Substituerte 6-cykloheksylalkylsubstituerte 2-kinolinoner og 2-kinoksalinoner som poly(ADP-ribose) polymeraseinhibitorer
NO20090581L (no) Hydroksylerte og metoksylerte syklopenta[D]pyrimidiner som AKT-proteinkinaseinhibitorer
NO20076554L (no) Pyrimidin- eller triazinkondenserte, bisykliske metalloproteaseinhibitorer
NO20071117L (no) Substituerte propenyl-piperazinderivater som nye inhibitorer av histondeacetylase
NO20062892L (no) 7-fenylalkyl-substituert 2-kinolinoner og 2-kinoksalinoner som poly(adp-ribose)-polymeraseinhibitorer
NO20073859L (no) Pyrrolopyrazoler, potente kinaseinhibitorer
EA200900779A1 (ru) Производные дигидропиридина, полезные как ингибиторы протеинкиназы
NO20063599L (no) Ytterligere heterosykliske forbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister
NO20061656L (no) 2,4 di(hetero)-arylamino-pyrimidin derivaer som ZAP-70 og/aller SYK inhibitorer
NO20060665L (no) N-substituerte pyrazolyl-amidyl-benzimidazolyl C-kit inhibitorer
NO20083207L (no) Inhibitorer av IAP
ATE386034T1 (de) Pyrazoloisoquinolinenderivaten als kinase inhibitoren
NO20063028L (no) 6-substituerte 2-kinolinoner og 2-kinoksalinoner som poly(adp-ribose)-polymeraseinhibitorer
NO20044221L (no) Nye forbindelser

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application